div class=ts-pagebuttonPage 1button div class=ts-image amp-img class=ts-thumb alt=Page 1: OGE - Transactional Records Access Clearinghousewith OGE review 2635802 2635403 5 CF R and approval 5 CF R S 3 801 b DOJ supplemental regulation prohibi ting certain src=https:reader033vdocumentsnetreader033viewer202206090660a1280cee085812cd2cbeb1html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 2button div class=ts-image amp-img class=ts-thumb alt=Page 2: OGE - Transactional Records Access Clearinghousewith OGE review 2635802 2635403 5 CF R and approval 5 CF R S 3 801 b DOJ supplemental regulation prohibi ting certain src=https:reader033vdocumentsnetreader033viewer202206090660a1280cee085812cd2cbeb1html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 3button div class=ts-image amp-img class=ts-thumb alt=Page 3: OGE - Transactional Records Access Clearinghousewith OGE review 2635802 2635403 5 CF R and approval 5 CF R S 3 801 b DOJ supplemental regulation prohibi ting certain src=https:reader033vdocumentsnetreader033viewer202206090660a1280cee085812cd2cbeb1html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 4button div class=ts-image amp-img class=ts-thumb alt=Page 4: OGE - Transactional Records Access Clearinghousewith OGE review 2635802 2635403 5 CF R and approval 5 CF R S 3 801 b DOJ supplemental regulation prohibi ting certain src=https:reader033vdocumentsnetreader033viewer202206090660a1280cee085812cd2cbeb1html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 5button div class=ts-image amp-img class=ts-thumb alt=Page 5: OGE - Transactional Records Access Clearinghousewith OGE review 2635802 2635403 5 CF R and approval 5 CF R S 3 801 b DOJ supplemental regulation prohibi ting certain src=https:reader033vdocumentsnetreader033viewer202206090660a1280cee085812cd2cbeb1html5thumbnails5jpg width=142 height=106 layout=responsive amp-img divdiv